Geron Corp. (GERN)

1.57 +0.06 (+3.97%) USD  |  NASDAQ  |  Sep 04, 16:00
1.57 0.00 (0.00%) After-Hours: 20:00
More

Geron SG&A Expense (TTM) : 154.96M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for GERN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 154.96M
March 31, 2026 154.66M
December 31, 2025 159.26M
September 30, 2025 160.96M
June 30, 2025 157.84M
March 31, 2025 158.69M
December 31, 2024 145.73M
September 30, 2024 123.76M
June 30, 2024 106.24M
March 31, 2024 83.31M
December 31, 2023 69.14M
September 30, 2023 61.58M
June 30, 2023 58.87M
March 31, 2023 49.82M
December 31, 2022 43.63M
September 30, 2022 37.66M
June 30, 2022 29.27M
March 31, 2022 28.89M
December 31, 2021 29.66M
September 30, 2021 28.88M
June 30, 2021 28.14M
March 31, 2021 27.04M
December 31, 2020 25.68M
September 30, 2020 23.85M
June 30, 2020 22.33M
Date Value
March 31, 2020 21.56M
December 31, 2019 20.89M
September 30, 2019 20.52M
June 30, 2019 19.79M
March 31, 2019 18.84M
December 31, 2018 18.71M
September 30, 2018 19.28M
June 30, 2018 19.78M
March 31, 2018 19.94M
December 31, 2017 19.29M
September 30, 2017 18.59M
June 30, 2017 18.48M
March 31, 2017 18.62M
December 31, 2016 18.76M
September 30, 2016 18.89M
June 30, 2016 18.56M
March 31, 2016 17.99M
December 31, 2015 17.79M
September 30, 2015 17.75M
June 30, 2015 17.49M
March 31, 2015 17.36M
December 31, 2014 16.76M
September 30, 2014 15.90M
June 30, 2014 15.29M
March 31, 2014 14.87M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Precigen, Inc. 84.93M
Editas Medicine, Inc. 45.51M
Agenus, Inc. 38.48M
Amgen, Inc. 7.019B
Anika Therapeutics, Inc. 52.67M